1. Cilostazol as a unique antithrombotic agent;J Kambayashi,2003
2. Cyclic nucleotide phosphodiesterase (PDE) super family: A new target for the development of specific therapeutic agents;C Lugnier,2006
3. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme;T Sudo,2000
4. U.S. Department of Health and Human Services, Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee 85th Meeting;M Packer;U.S. Department of Health and Human Services, Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee 85th Meeting,1998
5. Cilostazol and primary-PCI: mirage or good alternative?;I Porto,2012